Epithelial-Mesenchymal Transition, human (Scheel, 2011)
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr8_+_96493803 Show fit | 1.11 |
ENST00000518385.5
ENST00000302190.9 |
syndecan 2 |
|
chr11_+_114059702 Show fit | 0.83 |
ENST00000335953.9
ENST00000684612.1 ENST00000682810.1 ENST00000544220.1 |
zinc finger and BTB domain containing 16 |
|
chr8_-_13514821 Show fit | 0.80 |
ENST00000276297.9
|
DLC1 Rho GTPase activating protein |
|
chr5_+_83471736 Show fit | 0.76 |
ENST00000265077.8
|
versican |
|
chr7_-_47582076 Show fit | 0.72 |
ENST00000311160.14
|
tensin 3 |
|
chr22_-_28679865 Show fit | 0.61 |
ENST00000397906.6
|
tetratricopeptide repeat domain 28 |
|
chr10_-_79445617 Show fit | 0.61 |
ENST00000372336.4
|
zinc finger CCHC-type containing 24 |
|
chr1_-_83999097 Show fit | 0.58 |
ENST00000260505.13
ENST00000610996.1 |
tubulin tyrosine ligase like 7 |
|
chr14_-_29927801 Show fit | 0.55 |
ENST00000331968.11
|
protein kinase D1 |
|
chr11_-_2137277 Show fit | 0.52 |
ENST00000381392.5
ENST00000381395.5 ENST00000418738.2 |
insulin like growth factor 2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 1.1 | GO:0008218 | bioluminescence(GO:0008218) |
0.0 | 0.9 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.1 | 0.8 | GO:0051138 | positive regulation of NK T cell differentiation(GO:0051138) |
0.0 | 0.8 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.1 | 0.6 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
0.0 | 0.6 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.1 | 0.5 | GO:0045048 | protein insertion into ER membrane(GO:0045048) |
0.1 | 0.5 | GO:2000467 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.1 | 0.5 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.0 | 0.5 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 2.0 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 0.7 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.0 | 0.5 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 0.5 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.1 | 0.3 | GO:0097135 | cyclin E2-CDK2 complex(GO:0097135) |
0.1 | 0.3 | GO:0097513 | myosin II filament(GO:0097513) |
0.0 | 0.3 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.0 | 0.2 | GO:0043291 | RAVE complex(GO:0043291) |
0.0 | 0.2 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.0 | 0.2 | GO:0071203 | WASH complex(GO:0071203) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 0.8 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.0 | 0.7 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.0 | 0.7 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.6 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
0.0 | 0.5 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.0 | 0.5 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.0 | 0.5 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.0 | 0.5 | GO:0001968 | fibronectin binding(GO:0001968) |
0.1 | 0.4 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.1 | 0.4 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 1.0 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 0.8 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 0.7 | PID IGF1 PATHWAY | IGF1 pathway |
0.0 | 0.6 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 0.3 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.0 | 0.3 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 1.3 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 0.9 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.0 | 0.7 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.0 | 0.7 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.6 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 0.5 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 0.2 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |